FBIO Fortress Biotech, Inc. - Common Stock
$2.63
Price · May 20, 2026
52W Range
$2–$5
34% of range
Analyst Rating
BUY
8 analysts
Price Target
$11
+318% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
FBIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.63
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $5
FBIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
FBIO
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
FBIO
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
FBIO
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
FBIO
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
FBIO
Peer Median
FBIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
8 analysts
- Strong Buy 2 25.0%
- Buy 5 62.5%
- Hold 1 12.5%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-05-19
Median
$11.00
← Below all targets
$2.63
Low
$5.00
High
$17.00
Median target
$11.00
+318.3%
Mean target
$11.00
+318.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.07%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $-0.01 | $0.11 | -0.12% |
| Sept. 30, 2025 | $0.11 | $-0.43 | 0.54% |
| June 30, 2025 | $-0.50 | $-0.37 | -0.13% |
| March 31, 2025 | $-0.48 | $-0.50 | 0.02% |
| Dec. 31, 2024 | $-0.75 | $-0.77 | 0.02% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| FBIO | — | — | — | — | — | — |
| ANIX | $136M | -12.1 | 0.00% | — | -62.2% | — |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
| RNTX | — | -0.6 | — | — | — | — |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.